Universal Detection Technology is a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats.
The company today issued a response to the growing interest in the security and emergency response communities to protect first responders most susceptible to anthrax exposure. In other words, if there is a bioterrorism attack how can first responders preserve their own health and safety? For example, in the early stage of an inhalational anthrax attack, a one day delay in the initiation of chemoprophylaxis and treatment of exposed persons can result in thousands of additional deaths and millions of dollars of additional expenditures.
Therefore, the company believes that timely detection of an inhalation anthrax attack is crucial. Rapid detection is also important for disease outbreaks that result from other bioterrorism agents. Universal Detection Technologies has developed a range of products to accurately test for the presence of anthrax spores as well as other deadly bioagents.
Universal Detection Technologies’ 5-agent bioterrorism detection kits have been used extensively by first responders and private industry throughout the United States. The kits are designed to test for anthrax, botulinum toxin, ricin, plague (Y. Pestis) and other bioagents in as little as three minutes. Testing of the kits by the US Department of Defense as well as the military in the UK shows that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered “white powders”.